Insight Partners Takes a Contrarian Stance on AI Concentration
While much of the venture world continues to funnel capital into a small number of frontier AI labs, Insight Partners is charting a different course. Managing director Deven Parekh spoke openly about the firm's deliberate decision to stay diversified across the AI landscape, even as peers concentrate bets on OpenAI and Anthropic. The $90 billion firm holds stakes in competing AI labs and has no plans to abandon that posture. Parekh also addressed the firm's loss of portfolio company Legora to General Catalyst, framing it as an acceptable cost of a broader, hedged strategy. The firm's position is notable precisely because it runs against the grain of what many top-tier funds are doing right now.
Sector Spotlight: India's Semiconductor Boom
India's semiconductor industry has attracted significant capital in a short window of time. According to a new report, the sector has pulled in roughly:
- Indian semiconductor companies (sector aggregate), $1.4B raised, with nearly half of that amount coming in since 2025
The concentration of investment in the back half of that period signals that momentum is accelerating, not plateauing. Government-linked incentives, a growing domestic chip design talent pool, and global supply chain diversification pressures are all contributing to investor interest. India's semiconductor push is increasingly being treated as a structural opportunity rather than a speculative bet.
Early-Stage Watch: Bioscience Cohorts and Competition Capital
On the early-stage front, C-CAMP (the Centre for Cellular and Molecular Platforms) has selected 15 bioscience startups for the ninth edition of its National Bio Entrepreneurship Competition. While the competition itself does not represent a direct funding round, it functions as a pipeline accelerator with measurable downstream impact. Alumni of the program have collectively raised more than $125 million in venture funding across previous editions, making selection a credible signal of investability. The cohort spans life sciences, biotech tools, and adjacent areas, reflecting the breadth of India's emerging bioscience ecosystem.
Trends Worth Watching
A few patterns stand out across today's announcements. First, the debate over AI portfolio concentration is becoming more public, and Insight Partners is one of the few large firms willing to defend diversification on the record. That kind of institutional candor is rare and may reflect growing private anxiety about valuation risk at the top of the AI lab market. Second, India is showing up in two distinct sectors, semiconductors and bioscience, suggesting that the country's startup capital markets are maturing beyond software and fintech. The $1.4 billion figure in semiconductors alone, with half of it arriving since 2025, points to a funding cycle that is still in an early upswing. Third, competition-based pipelines like C-CAMP's program continue to serve a function that traditional seed funds often skip: de-risking deep science companies before they are ready for institutional capital. Taken together, today's stories point toward a market that is diversifying geographically and thematically, even as a vocal segment of the VC world remains laser-focused on a handful of U.S.-based AI incumbents.